The PE Ratio as of September 2024 (TTM) for Metacrine, Inc. (MTCR) is -0.48

According to Metacrine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.48. This represents a change of -30.07% compared to the average of -0.69 of the last 4 quarters.

Metacrine, Inc. (MTCR) Historical PE Ratio (quarterly & annually)

How has MTCR PE Ratio performed in the past?

The mean historical PE Ratio of Metacrine, Inc. over the last ten years is -4.72. The current -0.48 PE Ratio has changed 915.98% with respect to the historical average. Over the past ten years (40 quarters), MTCR's PE Ratio was at its highest in in the September 2020 quarter at -0.36. The PE Ratio was at its lowest in in the June 2020 quarter at -8.18.

Metacrine, Inc. (MTCR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Metacrine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Metacrine, Inc. (MTCR) Average PE Ratio

How has MTCR PE Ratio performed in the past?

The current PE Ratio of Metacrine, Inc. (MTCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Metacrine, Inc. (MTCR) PE Ratio vs. Peers

How is MTCR’s PE Ratio compared to its peers?

Metacrine, Inc.’s PE Ratio is less than Magenta Therapeutics, Inc. (-0.04), greater than Protara Therapeutics, Inc. (-0.97), less than TRACON Pharmaceuticals, Inc. (0.03), greater than Satsuma Pharmaceuticals, Inc. (-0.77), greater than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (9.46), greater than Assembly Biosciences, Inc. (-2.21), greater than Instil Bio, Inc. (-3.42), greater than Nuvation Bio Inc. (-1.47), greater than Vaccinex, Inc. (-0.58), greater than Monopar Therapeutics Inc. (-2.11), greater than Miromatrix Medical Inc. (-3.41), greater than Surrozen, Inc. (-0.52), greater than Anebulo Pharmaceuticals, Inc. (-5.80), greater than ZIVO Bioscience, Inc. (-2.68), greater than Indaptus Therapeutics, Inc. (-0.81),

Build a custom stock screener for Metacrine, Inc. (MTCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metacrine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Metacrine, Inc. (MTCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Metacrine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.